Contineum Therapeutics, Inc. (CTNM)
(Delayed Data from NSDQ)
$20.77 USD
-0.23 (-1.10%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $20.60 -0.17 (-0.82%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/15/24 |
---|---|
Current Quarter | -0.37 |
EPS Last Quarter | -3.55 |
Last EPS Surprise | -569.81% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.95 |
Next Year | -1.83 |
EPS (TTM) | NA |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | NA | NA | 50.00M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.37 | -0.39 | -1.95 | -1.83 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.35 | -0.36 | -1.86 | -1.79 |
Low Estimate | -0.39 | -0.42 | -2.03 | -1.86 |
Year ago EPS | NA | NA | NA | -1.95 |
Year over Year Growth Est. | NA | NA | NA | 6.15% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.37 | -0.39 | -1.95 | -1.83 |
7 Days Ago | -0.37 | -0.39 | -1.95 | -1.83 |
30 Days Ago | -0.37 | -0.39 | -1.95 | -1.83 |
60 Days Ago | -0.41 | -0.44 | -1.82 | -1.96 |
90 Days Ago | NA | NA | NA | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.37 | -0.39 | -1.95 | -1.83 |
Zacks Consensus Estimate | -0.37 | -0.39 | -1.95 | -1.83 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -3.55 | NA | NA | NA | NA |
Estimate | -0.53 | NA | NA | NA | NA |
Difference | -3.02 | NA | NA | NA | -3.02 |
Surprise | -569.81% | NA | NA | NA | -569.81% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more